Marker Therapeutics - Product Candidates
Product Candidates
Pipeline
Title 1Title 1
Title 2Title 2
PreclinicalPre
Phase IPh I
Phase IIPh II
Phase IIIPh III
Patient Specific
Allo
Acute Myeloid Leukemia - MT-401
Acute Myeloid Leukemia - MT-401
Auto
Lymphoma - MT-601
Lymphoma - MT-601
Pancreatic Cancer - MT-601
Pancreatic Cancer - MT-601
2022 IND
Solid Tumors
Off-the-shelf
Acute Myeloid Leukemia - MT-401-OTS
Acute Myeloid Leukemia - MT-401-OTS
1st patient 2023

Solid Tumors Hematologic malignancy